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Despite the important role that insulin plays in the human body, very little is known about its presence in human milk. Levels
rapidly decrease during the ﬁrst few days of lactation and then, unlike other serum proteins of similar size, achieve comparable
levels to those in serum. Despite this, current guides for medical treatment suggest that insulin does not pass into milk, raising the
question of where the insulin in milk originates. Five mothers without diabetes, 4 mothers with type 1, and 5 mothers with type 2
diabetes collected milk samples over a 24-hour period. Samples were analysed for total and endogenous insulin content and for c-
peptide content. All of the insulin present in the milk of type 1 mothers was artiﬁcial, and c-peptide levels were 100x lower than in
serum. This demonstrates that insulin is transported into human milk at comparable concentration to serum, suggesting an active
transport mechanism. The role of insulin in milk is yet to be determined; however, there are a number of potential implications
for the infant of the presence of artiﬁcial insulins in milk.
1.Introduction
Insulin, a key hormone in blood glucose homeostasis, has
been detected in human colostrum at supraphysiological
levels (114–306mU/L) before decreasing to similar concen-
trations to those found in blood in the fasting state by day 5
postpartum in healthy mothers [1, 2]. Recent work by Tiit-
tanen et al. [3] has demonstrated that insulin is also present
in the milk of mothers with type 1 diabetes mellitus, who
lack any endogenous insulin secretion from the pancreas.
They alsodemonstrated thatlevelsof insulin are signiﬁcantly
higher (P<0.001) in milk from type 1 diabetic mothers
than that of nondiabetic control mothers, at both days 3
to 7 postpartum and 3 months postpartum. Interestingly,
insulin levels in the milk of control mothers vary greatly
between studies, while those reported by Shehadeh et al.
[4] showed higher milk insulin concentrations than those
reported by Tiittanen et al. [3], suggesting that signiﬁcant
variation exists between mothers regardless of the presence
of diabetes mellitus. However, the work by Tiittanen et al.
[3] and Shehadeh et al. [4] does not further the time of
collection or fasting state of mothers, which may account
for some of the variability observed. In addition, Kulski and
Hartmann [2] have demonstrated that the levels of insulin
in breastmilk may vary with the stage of lactation, with high
levels present in colostrum and levels decreasing to a plateau
in established lactation. Despite this, current medical guides
state that insulin is a peptide that is too large to be secreted
into milk [5–7].
Given the established role of dietary insulin in the
maturation of intestinal epithelium in rats, it can be
postulated that insulin present in milk may play a similar
role in the development of human intestinal epithelium
[8, 9]. Additionally, work in rats has shown that a trypsin
inhibitor present in milk acts to preserve insulin function
[10, 11]. Furthermore, epithelial cell insulin receptors exist
in the intestine of both piglets and calves, and insulin has
been suggested to play a role in inﬂuencing growth and2 International Journal of Endocrinology
development of the small intestine [12, 13]. This would
suggest that insulin could retain biological activity when
ingested by the infant and that intact insulin may pass over
from the gastrointestinal tract of infants into blood. This
suggestion is further supported and extensively discussed in
a review of the in vivo and in vitro eﬀects of insulin on the
gastrointestinal tract by Shehadeh et al. [14].
Endogenous insulin typically exists in blood in equilib-
rium between a free monomeric state and a hexamer with
zinc; it is only able to bind to receptors in the free state
and has a half-life of ∼20 minutes [15]. A recombinant
human protein is typically used for therapy. Due to the
relatively short half-life, a number of short- or long-acting
variants have been developed, either by modifying the
amino acid sequence to prevent hexamer formation, or
through complexing to zinc or protophane to shift the
equilibriumtowardsthehexamericstate[6,16].Duetothese
modiﬁcations to the amino acid sequence, speciﬁc assays
can be used to identify whether the insulin present in a
ﬂuid sample is endogenous or a modiﬁed exogenous form
of insulin [17, 18].
Tiitannen et al. [3] demonstrated that human dietary
insulin in milk may have a tolerogenic eﬀect against bovine
insulin in formula and downregulate the production of
IgG antibodies to bovine insulin, protecting against the
development of autoimmunity, as shown with decreased
levels of IgG to insulin in breast-fed children compared to
those fed with cow’s milk formula containing bovine insulin.
Despite this beneﬁcial eﬀect at lower milk insulin levels, they
alsonotedthathighendogenousinsulinlevelsinhumanmilk
were associated with a signiﬁcantly increased incidence of β-
cell autoimmunity in children, in both control mothers (P =
0.030) and mothers with type 1 diabetes (P = 0.045), which
may suggest that exposure to high levels of endogenous
insulin can also promote autoimmunity. However, it must be
noted that this does not imply that development of type 1
diabetes mellitus is similarly promoted. In contrast to this,
other recent work has demonstrated that administration of
oral insulin may help protect residual β-cell function in
children and adults with recent-onset type 1 diabetes [4, 19,
20]. Other work has supported the possible role of breast
milk in the prevention of type 1 diabetes mellitus [21], since
there is a lower incidence of type 1 diabetes in breast-fed
children,butthisisstillacontroversialareaandcontendedby
other sources [22–24]. The eﬀects that type 2 and gestational
diabetes mellitus may have on insulin concentration in milk
have not yet been identiﬁed.
Given that the only known source of insulin in mothers
with type 1 diabetes is injected exogenous insulin, this allows
the hypothesis that either insulin is being transported into
human milk, in contrast to current literature, or that it is
being synthesised in the mammary gland and then secreted
into the milk. There are currently no studies comparing
the levels of exogenous insulin in milk compared to that
produced endogenously in mothers with or without diabetes
mellitus. The purpose of this study was to identify the origin
of the insulin present in the milk of mothers with type
1 diabetes mellitus as either endogenous or exogenous by
determining the levels of total insulin, endogenous insulin,
and c-peptide in the milk compared to mothers without
diabetes mellitus. This study also aimed to compare the
levels of insulin in breast milk from mothers with type 2
diabetes and then investigate any relationship between blood
glucose,milkinsulin,glucose,c-peptide,andsodiumcontent
in breast milk in each of the groups. Mothers with type 2
diabetes mellitus have been included in order to compare
insulinconcentrationsandastheyshouldhavenoexogenous
insulin present in their milk or blood.
2. Methods
2.1. Patients. Samples from ﬁve control mothers (without
diabetes mellitus) all in established lactation between 1 to
6 months were randomly selected from 24-hour production
milk stock collected by the Lactation Research Group. Exact
stateoflactationisnotfurtherspeciﬁed,asitwasnotrelevant
to the aims of this study in identifying the origin of insulin
in milk. These mothers were designated T0-01 through T0-
05. Mothers with diabetes mellitus were recruited from the
Diabetes clinic at King Edward Memorial Hospital, Western
Australia. Four mothers with type 1 diabetes mellitus were
recruited, and all mothers in this group were on insulin
replacement therapy. These mothers were designated T1-01
through T1-04. Five mothers with type 2 diabetes mellitus
were recruited, and all mothers in this group was on
dietary, exercise or metformin treatment, or a combination
of these. None of the mothers in this group were on insulin
replacement therapy. These mothers were designated T2-01
through T2-05. One mother in the type 1 group (T1-04)
was lost to followup. All mothers in the three groups were
breast feeding at the time and within 4 months postpartum.
Details and demographic data for the mothers recruited are
provided in Table 1. All mothers supplied written informed
consent to participate, and the study was approved by the
Human Research Ethics Committee, King Edward Memorial
Hospital.
2.2. Milk Collection. Mothers were asked to perform a single
24-hour milk collection. This involved collecting 1 to 2mL
of fore and hind milk from each breast used at each feed
for a period of 24 hours. Mothers fed infants 7–12 times
per day from either one or both breasts. Fore and hind
milk samples were collected from each feed. Feed times were
at 2–4 hour intervals at all times of the day. There were
a varying number of feeds per day per mother, depending
on infant hunger and the breast used (single versus both).
Samples were collected before and after a feed from each
breast used for each feed. Some time points were a feed from
a single breast—so samples were collected before and after
the feed for that breast only. Other time-points involved a
breastfeed from each breast so samples were collected before
and after a feed from both the left and right breast. Sample
analysis in this and previous studies has shown no diﬀerence
in milk composition between left and right breasts so this
data was analysed collectively. All samples were frozen by
the mothers, and then transported to the laboratory and
storedat −30◦Cpriorforanalysis.SampleswerethenthawedInternational Journal of Endocrinology 3
Table 1: Demographic details of mothers with diabetes.
ID Age Type of diabetes HbA1c
Method of
deliveryA Medications Stage of lactation
T1-01 23 1 6.7 V Novorapid + lantis 5 months
T1-02 36 1 5.4 C Novorapid + lantis 4 months
T1-03 32 1 4.8 C Novorapid + lantis 2.5 months
T1-04∗ 27 1 7.4 C (E) Novorapid + lantis 2 months
T2-01 32 2 5.9 V Metformin + diet 4 months
T2-02 32 2 5.1 V (A) Metformin + diet 3 months
T2-03 37 2 — C Metformin + diet N/A
<6m o n t h s
T2-04 27 2 6.0 C Diet 3 months
T2-05 27 2 5.0 V Diet 10 days
AV denotes vaginal delivery; A denotes assisted; C denotes Caesarean section; E denotes emergency.
∗mother lost to followup.
to 37◦C, mixed, and centrifuged at 3,000 RPM (05PR-22
Refrigerated Centrifuge, Hitachi) for 10 minutes at 4◦Ci n
300μL polypropylene tubes to separate the fat from the skim
layer. Defatted milk was either immediately used for analysis
or stored in appropriately labeled Eppendorf tubes (0.5 to
1.5mL) and frozen at −30◦C for later analysis.
2.3. Sample Analysis. Milk samples were analysed for glucose
content using the spectrophotometric method described by
Arthur et al. [25]. Defatted milk samples were analysed
for total insulin content (endogenous + exogenous) using
a chemiluminescent microparticle immunoassay (CMIA),
which was performed at PathWest (PathWest Laboratory
Medicine WA, QEII Medical Complex, Sir Charles Gairdner
Hospital, Western Australia). Endogenous insulin content
of defatted milk samples was measured using the Mercodia
AB “Insulin ELISA” kit, as described in the kit insert
[18]. C-peptide content of milk samples was similarly
determined using the Mercodia AB “C-peptide ELISA” kit
[26]. Total insulin content was additionally calculated using
the Mercodia AB “Iso-Insulin ELISA” kit, along with the
CMIA method described earlier [18]. The isoinsulin assay
detectsendogenousinsulin,alongwiththeexogenousinsulin
formulations (insulin aspart, detemir, glargine, glulisine,
and lispro), compared to the standard insulin assay, which
is speciﬁc for endogenous insulin only. Exogenous insulin
content was calculated by subtracting endogenous insulin
content from total (endogenous and all modiﬁed forms)
insulin content [27]. Two techniques were used to analyse
total insulin content (CMIA + ELISA) in order to assess
suitability of the CMIA method for milk analysis; if appro-
priate, it could then be used in a larger-scale study as a more
cost + time-eﬀective approach to analysis of milk insulin
content. The recovery, detection, and interassay coeﬃcient
of variation are presented in Table 2. Insulin content was
measured for all samples, including fore + hind milk for each
feed (n = 199).
Total fat content of the milk samples was assessed using
the creamatocrit method described by Lucas et al. [28].
Finally, milk sodium analysis was performed using an atomic
absorption spectroscopy approach, using a Varian Techtron
absorption spectrophotometer model A100. Haemoglobin
A1c (HbA1c) was also documented from routine analysis in
pregnancy for those mothers with diabetes.
2.4. Statistical Analysis. Although only a small number of
mothers were present in each group, the large number of
milk samples collected by each mother over the 24 hours
periods allows for statistical analysis of diﬀerences between
groups.
Diﬀerences between types of diabetes and between
mothers were calculated using a repeated measures linear
mixed-eﬀects model, in order to take into account diﬀerent
numbers of feeds per day and diﬀering numbers of mothers
in each group. This was performed using the statistical
functions of R (version 2.5.1, the R foundation for statistical
computing). Unless otherwise stated, allresults are presented
as mean ± SEM. P values < 0.05 are considered signiﬁcant.
3. Results
3.1. Insulin Content of Fore and Hind Milk. Total insulin
content of fore and hind milk samples was measured in all
samples (n = 199) using the CMIA method and showed
good correlation between the content of fore and hind milk
samples when all mothers were considered, as shown in
Figure 1. Analysis of individual groups showed no signiﬁcant
diﬀerence in insulin content of fore and hind milk between
groups (P = 0.20, P = 0.98, and P = 0.14 for control, type 1,
and type 2, resp.). Based on this, fore and hind milk insulin
levels were averaged for the purpose of investigating any
circadian variation; and this analysis showed no signiﬁcant
variation ininsulin levelsduring diﬀerenttime points during
the day. While there was circadian variation evident for
all mothers, there was no consistent trend evident when
analyzing as a group (data not shown).
3.2. Origin of Insulin in Human Milk. In order to determine
whether the insulin present in the milk of mothers with
type 1 diabetes is synthesised in the mammary gland or is4 International Journal of Endocrinology
Table 2: Insulin assay veriﬁcation.
Assay Recovery Detection limit Interassay coeﬃcient
of variation
Insulin CMIA 100.91 ±4.99% 1.32 mU/L 0.62%
Endogenous insulin
ELISA 95.00 ±3.60% 0.188 mU/L 2.69%
Total insulin ELISA 96.91 ±7.69% 4.93 mU/L 9.49%
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Figure 1:Correlationbetweentotalinsulincontentofforeandhind
milk by CMIA method for all samples (r = 0.8413, P<0.001, n =
199 all fore + hind milk samples).
transported from blood, total and endogenous insulin levels
were measured in all milk samples in this group (n = 53).
Exogenous insulin content was calculated as total insulin
minus endogenous insulin for each sample. Mean ± SEM
exogenous insulin levels in the milk of mothers with type 1
diabetes were 12.22 ± 1.34mU/L for mother T1-01, 31.54 ±
4.95mU/L for mother T1-02, and 17.86 ± 4.34mU/L for
mother T1-03. There was no detectable endogenous insulin
content in the milk of mothers with type 1 diabetes;
therefore, all insulin detected in the milk of mothers with
type 1 diabetes was of exogenous origin.
3.3. Total Insulin Content in Human Milk. I no r d e rt oi n v e s -
tigate variations in insulin concentration between control
mothers and mothers with diabetes, total insulin content of
each milk sample (fore + hind milk individually) from each
mother was measured using the CMIA technique (n = 199).
There was no signiﬁcant diﬀerence between fore and hind
milk insulin content, so further data algorithmically treats
each data point as the mean of fore + hind milk for each
feed (time point). Total insulin content from all samples is
presented in Figure 2, along with the mean insulin content
of each group. The control mother T0-03 demonstrated
signiﬁcantly higher milk insulin content than the other
control mothers (78.23 ± 3.96 versus 15.46 ± 1.03 mU/L,
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Figure 2: Total Insulin content of each milk sample (fore and hind
m i l k )c o l l e c t e df o ra l lm o t h e r sa sm e a s u r e db yt h eC M I Am e t h o d .
Dark lines indicate the mean for each group. The dotted line
indicates the mean for the control group with the outlier mother
T0-03 removed.
P<0.001). There was no signiﬁcant diﬀerence in mean
insulin content between control mothers and mothers with
type 1 diabetes (P = 0.74), control mothers and mothers
with type 2 diabetes (P = 0.93), or between mothers with
type 1 and type 2 diabetes (P = 0.62).
3.4. C-Peptide Content of Human Milk. Insulin is produced
by cleaving insulin and c-peptide from the precursor
molecule proinsulin. Hence, c-peptide content of the milk
fromtwomotherswithtype1diabetesand3controlmothers
was measured using the ELISA method described (n = 61).
C-peptide was detected in all samples; however, levels in
the milk of control mothers were signiﬁcantly higher than
those in mothers with type 1 diabetes (21.09 ± 1.00 versus
14.49 ± 1.47pmol/L, P<0.01). There was no signiﬁcant
correlationbetweenc-peptideandtotalinsulincontentintheInternational Journal of Endocrinology 5
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Figure 3: Mean sodium content of milk in each group. ∗indicates
signiﬁcant diﬀerence (P<0.05) compared to control mothers.
milk of control mothers (P = 0.79) or mothers with type 1
diabetes (P = 0.85).
3.5. Sodium Content of Human Milk. I no r d e rt oi n v e s t i g a t e
the transport of insulin into human milk, the sodium
content of the milk from all mothers was measured using
atomic absorption spectroscopy (n = 199) as a marker of
permeability of the paracellular pathway [29]. Mean sodium
concentrations in milk are presented in Figure 3.
There was signiﬁcantly lower sodium content in the
milk of mothers with type 1 diabetes compared to control
mothers (P<0.05), but no signiﬁcant diﬀerence in mean
sodium content between control mothers and mothers with
type 2 diabetes (P = 0.09) or between types of diabetes
(P = 0.54). There was no signiﬁcant relationship between
sodium and insulin content of milk for control mothers
(P = 0.17) or mothers with type 1 diabetes (P = 0.37),
but a mild negative correlation existed for mothers with
type 2 diabetes (r =− 0.34, P<0.05). Additionally,
for the outlier control mother T0-03 who demonstrated
signiﬁcantly elevated insulin levels in milk, there was no
signiﬁcant relationship between sodium and insulin content
in milk (P = 0.61).
3.6. Blood Glucose Levels and Milk Insulin Content. In order
to investigate any correlation between blood glucose levels
and insulin content in the milk of mothers with type 1 and
2 diabetes, mothers were asked to record their blood glucose
levels at least 4 times over the course of the same 24-hour
period as their milk sample collection. There was a great deal
of variation within mothers for each group over a 24-hour
period for both milk insulin and blood glucose; however,
no signiﬁcant consistent trends were identiﬁed. However,
there was no signiﬁcant diﬀerence (P = 0.15) in mean
blood glucose levels between mothers with type 1 and type
2 diabetes. Mean blood glucose levels in mothers with type 1
diabeteswere8.52±0.57mmol/L,andlevelsformotherswith
type 2 diabetes were 7.45 ±0.26mmol/L (mean ± SEM).
There was no signiﬁcant relationship between mean
blood glucose levels and mean milk insulin levels in mothers
with type 1 diabetes (P = 0.72) or mothers with type 2
diabetes (P = 0.16). By comparing blood glucose levels
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Figure 4: Mean glucose content of milk in each group. ∗indicates
signiﬁcant diﬀerence (P<0.05) compared to control mothers.
and milk insulin concentration over time, there appears to
be an inverse relationship between the two; a reduction
in blood glucose levels is mirrored by an increase in milk
insulin content. However, this does not hold true for all
mothers. Mother T2-05 (type 2) demonstrated only small
variability in milk insulin content, and mother T2-03 (type
2) demonstrated large variability in milk insulin content
with only small variation in blood glucose levels. Limited
blood glucose data was provided by mothers due to sample
collection diﬃculties, and further comparison is not possible
within the scope of this paper.
3.7. Glucose Content of Human Milk. As the glucose present
in human milk derives from blood glucose, there may be
ﬂuctuations in milk glucose content that correlate with
either blood glucose levels or insulin content of milk.
Glucose content of each sample (fore and hind milk) was
measured using the spectrophotometric method described.
Mean glucose concentration in each group is shown in
Figure 4.
There was signiﬁcantly higher glucose content in the
milk of mothers with type 1 diabetes compared to control
mothers (P<0.05) and in the milk of mothers with type
2 diabetes compared to control mothers (P<0.05), but no
signiﬁcant diﬀerence in milk glucose content between types
of diabetes (P = 0.68). There was no signiﬁcant correlation
between milk and blood glucose levels for mothers with
type 1 diabetes (P = 0.60) or mothers with type 2 diabetes
(P = 0.33). There was no signiﬁcant relationship between
glucose and insulin content of milk in control mothers (P =
0.17) or mothers with type 2 diabetes (P = 0.11), but
there was a slight negative correlation between glucose and
insulin content in milk from mothers with type 1 diabetes
(r =− 0.41, P<0.01).
4. Discussion
Most current medical references state that insulin is too
large to cross over from blood into milk [5–7]. However,
there have been continuous references in the scientiﬁc
literature to the presence of insulin in milk and the presence
of elevated levels in the milk of mothers with diabetes6 International Journal of Endocrinology
compared to mothers without diabetes [1–3, 30]. Based on
this conﬂicting evidence, it is proposed that insulin could
either be transported into milk or be synthesised in the
mammary gland and directly secreted into milk. This is a
novel concept and ﬁrst proposed in this pilot study.
4.1. Origins of Insulin in Human Milk. The origin of insulin
in milk was determined through two approaches. Firstly,
the type of insulin present in the milk of mothers with
type 1 diabetes mellitus was assessed. These mothers should
have no endogenous insulin production from the pancreas,
and all insulin present in their blood should result from
injections of exogenous insulin. Analysis of the milk of
these mothers revealed that there was no endogenous insulin
present, suggesting that it was all derived from injected
insulin present in blood.
Secondly, the presence of c-peptide in the milk of two
mothers with type 1 diabetes and three control mothers
was measured. As the endogenous ELISA used is highly
speciﬁc for human insulin, it was possible that any insulin
synthesised in the mammary gland may be suﬃciently
structurally diﬀerent to insulin synthesised in the pancreas
as to not be detected by the ELISA, as is seen the two
human isoforms of apolipoprotein B (ApoB48, synthesized
in the small intestine, and ApoB100, synthesized in the liver)
[31]. As insulin and c-peptide are cleaved from proinsulin in
equimolar quantities [32], if insulin was synthesised in the
mammary gland, then there should be equimolar quantities
of both present in milk. C-peptide was identiﬁed in milk
mothers with type 1 diabetes, but at 15 to 20x lower than
reference blood concentrations [33], despite the common
view that patients with type 1 diabetes do not produce
insulin. However, many patients with type 1 diabetes still
retainsomeresidualpancreaticβ-cellfunction,andinsulinis
secreted at subphysiological levels alongside c-peptide [34].
These factors indicate that the insulin present in milk is
derived from insulin in blood.
4.2. Transport of Insulin into Human Milk. Insulin content
in milk for all groups was found to be similar to known
reference levels for blood. This is the ﬁrst time insulin levels
havebeenanalysedinmilkfrommotherswithtype2diabetes
and is in concordance with previous work investigating
insulin concentration in the milk of control mothers and
mothers with type 1 diabetes [1–3]. In contrast to other
serum proteins of similar size, which are normally present
in milk at up to 100x lower concentration than found in
blood [35], these results suggest that insulin does not diﬀuse
into milk via the paracellular pathway. This is supported
by the lack of any correlation between insulin and sodium
content of milk for control mothers and mothers with
type 1 diabetes; as sodium content of milk is an indicator
of the permeability of the paracellular pathway, a positive
correlation between insulin and sodium content of milk
would be expected if insulin was entering via the paracellular
pathway. Additionally, sodium content was signiﬁcantly
lower in mothers with type 1 diabetes than in controls,
suggesting that the paracellular pathway is closed in these
mothers. There was no signiﬁcant diﬀerence in sodium
content of milk between mothers with type 2 diabetes and
control mothers.
These ﬁndings suggest that insulin must be actively
transported into milk in order to achieve these higher
concentrations.Twoinsulin transporters havecurrentlybeen
identiﬁed; an active transporter present on the blood brain
barrier (BBB) and receptor-mediated endocytosis of insulin
occurring in skeletal muscle endothelium [36, 37]. As the
BBB transporter is only capable of establishing a cerebral
concentration of less than 10% of the systemic blood
concentration, it is unlikely to be involved in transport
of insulin in the mammary gland. However, the transport
system in the skeletal muscle endothelium is capable of
transporting insulin at up to 50% of blood levels. While
this is still lower than the ∼100% transfer seen in the
mammarygland,asmilk issynthesised overaperiod oftime,
this could potentially account for the high concentrations
present in milk. Further consideration must be given to
the supraphysiological insulin concentrations demonstrated
in human colostrum, and how these are achieved [2].
While this study did not assess colostrum insulin content, it
can be postulated that the potential milk trypsin inhibitor
postulated in rat models may act to preserve and stabilize
insulin within milk, leading to these higher concentrations
[10,11].Alternately,activetransportofinsulinintomilkmay
increase in the colostrum phase, particularly if insulin does
indeed play a large role in maturation of the infant digestive
system [13, 14]. Further research into insulin transport
mechanisms in both colostrum and normal milk is required
to better investigate this possibility.
There was no signiﬁcant diﬀerence between the levels of
insulin in the milk of control mothers, mothers with type
1, and mothers with type 2 diabetes, despite the insulin
present in the type 1 mothers being artiﬁcial in nature. This
suggests that the exogenous insulin used for treatment of
type 1 diabetes is transported into milk with similar aﬃnity
to endogenous insulin in mothers without diabetes.
As the exact transport mechanism has yet to be scientiﬁ-
cally quantiﬁed, the signiﬁcantly elevated milk insulin levels
in control mother T0-03 cannot be readily explained. If milk
insulin concentration does reﬂect or mirror blood insulin
concentrations, then the elevated insulin levels seen would
typically represent a woman with undiagnosed, untreated
type 2 diabetes [38]. However, as the transporter has yet
to be identiﬁed, the possibility remains that the elevated
milk insulin levels in this mother are due to altered insulin
transport, rather than elevated blood insulin levels; as two
isoforms of the insulin receptor exist, it is possible that
the high speciﬁcity isoform may be preferentially expressed
in the mammary gland of this mother, thus resulting in
increased insulin transport into her milk [39].
4.3. Blood Glucose Levels and Milk Insulin Concentration.
Varying data exists in the literature as to the glucose
content of milk in mothers with diabetes. It has been
established by Neville et al. [29] that glucose transport into
milk is insulin independent and dependent upon bloodInternational Journal of Endocrinology 7
glucose concentrations. Given this, it would be expected
that patients with diabetes would have elevated milk glucose
levels, reﬂecting their typically elevated blood glucose levels
[15]. This study identiﬁed signiﬁcantly higher milk glucose
concentrations in mothers with type 1 and type 2 diabetes
compared to control mothers, as was predicted. There was
nocorrelationwithmaternalbloodglucoselevels,incontrast
to data reported by Jackson et al. [40]. However, this may be
a result of only being able to compare the mean blood and
milk glucose levels for each mother; the study by Jackson
et al. [40] compared the direct relationship between blood
glucose and milk glucose at time of expression. This ﬁnding
andtheinverserelationshiphavebeenincludedasapotential
important course of future investigation.
4.4. Potential Roles of Milk Insulin. This study demonstrated
that both exogenous and endogenous insulin, are actively
transported into human milk in similar concentrations to
those found in blood, in comparison to other serum proteins
of similar or smaller size, such as c-peptide. Presumably milk
insulin must therefore play a functional or developmental
role in the infant. Studies in a rat model have demonstrated
that oral insulin in milk is involved in maturation of intesti-
nal epithelium and induces pancreatic amylase development
at weaning [8, 10, 11]. It has also been demonstrated
to inﬂuence lactase and saccharase activity in the small
intestine in a piglet model [13]. A series of papers reported
by Koldovsk´ y[ 1] show that human infants demonstrate
decreased blood glucose levels in response to milk insulin in
early development, suggesting that intact insulin is crossing
into the bloodstream of the infant. Similarly, work by
Mosinger et al. [41] also showed that suckling rats exhibit
decreased blood glucose levels in response to oral insulin,
whereas weaned rats do not. This is of particular importance
in neonatal care, as infants of mothers with diabetes are
frequentlyretainedintheneonatalintensivecareunitandfed
expressed breast milk from their mothers [42]. These infants
could potentially then remain hypoglycaemic for longer
periods, in contrast to the intended aim of the protocol.
Tiittanen et al. [3] showed that dietary nonhuman
insulin can potentially act as an immunogen and predispose
the infant to formation of anti-insulin antibodies, while
low levels of human insulin in milk can act as a tolerogen
to downregulate any immune response to foreign dietary
insulin. Their study investigated the presence of bovine
insulininformulaasthepotentialimmunogen,whichisonly
three amino acids diﬀerent in sequence to human insulin.
Giventhispotentialimmunogenicroleofnonhumaninsulin,
it is important to consider the potential implications of
the presence of artiﬁcial insulin in human milk. Artiﬁcial
recombinant human insulins that are currently used as
treatment for patients with type 1 diabetes are typically
also only one to three amino acids diﬀerent in sequence to
human insulin [17]. It can therefore be hypothesised that
the presence of artiﬁcial insulin in the milk of mothers with
type1diabetesmaybeactingasanimmunogen,whichcould
potentially increase the risk of the infant developing auto-
immune diseases in later life. As this immunogenic eﬀectwas
demonstrated in both early and late lactation, it is possible
that insulin is being degraded and only peptide fragments
are entering the blood from the intestine. However, given
the diﬀerence noted in immunogenicity, it is likely that
those breakdown products that enter blood still contain
the sequence regions that diﬀer between recombinant and
endogenousinsulin.However,thedataintheliteratureofthe
role of breastfeeding on the development of type 1 diabetes
mellitus in control mothers and those with type 1 diabetes
mellitus is still controversial and that the rate of diabetes
mellitus in children of type 1 diabetic mothers is lower
than in the general population, further suggesting a potential
tolerogenic eﬀect of milk insulin [22–24].
4.5. Limitations. A number of limitations must be taken
into consideration when interpreting the results of the
above study. Firstly, as a pilot study, there are only a
small number of participants and hence a low sample
size. A repeated measures model and a large number of
samples per participant are used to counter this, but the
low sample size may limit the interpretation of trends of
other milk components. However, this should not aﬀect
interpretation of human milk insulin origin as exogenous or
endogenous. Further, the speciﬁcity of the ELISA assays used
for identiﬁcation of human pancreatic insulin compared
to modiﬁed exogenous insulin forms means that if there
were any structural diﬀerences between human pancreatic
and a hypothetical mammary source, then the mammary
insulin may not be detected with this assay. Finally, there
was a signiﬁcant lack of blood glucose concentration data to
compare to milk glucose and milk insulin, due to collection
diﬃculties with mothers involved in this study.
4.6. Future Directions. This study has identiﬁed that both
endogenous and exogenous insulin is transported from
blood into human milk. However, the exact method of
transfer still needs to be identiﬁed and characterised. Studies
inaratmodelwithlabelledartiﬁcialinsulincouldpotentially
beusedtoidentifythesourceoftransferintomilk,anduseof
a hyperinsulinaemic clamp model may be used to determine
(a) the rate of transfer and (b) the transport maximum for
the mammary gland transporter.
Given that insulin is actively transported into human
milk and is protected from degradation, it presumably plays
a functional or developmental role in the infant. Given this,
the presence of insulin in formula products needs to be
reassessed; as not all mothers will breast-feed their infants,
if insulin plays a functional or developmental role then
the addition of insulin to formula could potentially act to
improve the similarities of formula to human milk and thus
be beneﬁcial to the health and development of formula-fed
infants.
Conﬂict of Interests
The authors declare that there are no conﬂicts of interests
associated with this paper.8 International Journal of Endocrinology
Acknowledgment
This study was supported by funds from Medela AG,
Switzerland.
References
[1] O. Koldovsk´ y, “Hormones in Milk,” Vitamins & Hormones,
vol. 50, pp. 77–149, 1995.
[2] J. K. Kulski and P. E. Hartmann, “Milk insulin, GH and TSH:
relationship to changes in milk lactose, glucose and protein
duringlactogenesisinwomen,”EndocrinologiaExperimentalis,
vol. 17, no. 3-4, pp. 317–326, 1983.
[3] M. Tiittanen, J. Paronen, E. Savilahti et al., “Dietary insulin
as an immunogen and tolerogen,” Pediatric Allergy and
Immunology, vol. 17, no. 7, pp. 538–543, 2006.
[4] N. Shehadeh, E. Khaesh-Goldberg, R. Shamir et al., “Insulin
in human milk: postpartum changes and eﬀect of gestational
age,” Archives of Disease in Childhood, vol. 88, no. 3, pp. F214–
F216, 2003.
[ 5 ] G .G .B ri g gs ,R .K .F r e e m a n ,a n dS .J .Y a ﬀe, DrugsinPregnancy
and Lactation: A Reference Guide to Fetal and Neonatal Risk,
Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 7th
edition, 2005.
[ 6 ]T .W .H a l e ,Medications and Mothers’ Milk,P h a r m a s o f t ,
Amarillo, Tex, USA, 12th edition, 2006.
[ 7 ] J .P .S p e n c e r ,L .S .G o n z a l e zI I I ,a n dD .J .B a r n h a r t ,
“Medications in the breast-feeding mother,” American Family
Physician, vol. 64, no. 1, pp. 119–126, 2001.
[8] J. P. Buts, N. De Keyser, and C. Dive, “Intestinal development
in the suckling rat: eﬀect of insulin on the maturation of
villus and crypt cell functions,” European Journal of Clinical
Investigation, vol. 18, no. 4, pp. 391–398, 1988.
[9] S. Marandi, N. De Keyser, A. Saliez et al., “Insulin signal
transduction in rat small intestine: role of MAP kinases
in expression of mucosal hydrolases,” American Journal of
Physiology, vol. 280, no. 2, pp. G229–G240, 2001.
[10] T. Kinouchi, K. Koizumi, T. Kuwata, and T. Yajima, “Milk-
borneinsulinwithtrypsininhibitorinmilkinducespancreatic
amylase development at the onset of weaning in rats,” Journal
of Pediatric Gastroenterology and Nutrition,v o l .3 0 ,n o .5 ,p p .
515–521, 2000.
[11] R. J. Shulman, “Oral insulin increases small intestinal mass
and disaccharidase activity in the newborn miniature pig,”
Pediatric Research, vol. 28, no. 2, pp. 171–175, 1990.
[12] I.P .Georgiev ,T .M.Georgieva,M.Pfaﬄ,H.M.H ammon,and
J.W.Blum,“Insulin-likegrowthfactorandinsulinreceptorsin
intestinalmucosaofneonatalcalves,”JournalofEndocrinology,
vol. 176, no. 1, pp. 121–132, 2003.
[13] R. J. Shulman, D. R. Tivey, I. Sunitha, M. A. Dudley, and S. J.
Henning,“Eﬀectoforalinsulinonlactaseactivity,mRNA,and
posttranscriptional processing in the newborn pig,” Journal
of Pediatric Gastroenterology and Nutrition,v o l .1 4 ,n o .2 ,p p .
166–172, 1992.
[14] N. Shehadeh, I. Sukhotnik, and R. Shamir, “Gastrointestinal
tract as a target organ for orally administered insulin,” Journal
of Pediatric Gastroenterology and Nutrition,v o l .4 3 ,n o .3 ,p p .
276–281, 2006.
[15] R. A. DeFronzo, International Textbook of Diabetes Mellitus,
John Wiley & Sons, Hoboken, NJ, USA, 3rd edition, 2004.
[16] R. M. Bergenstal, “Eﬀective insulin therapy,” in Interna-
tional Textbook of Diabetes Mellitus,R .A .D e F r o n z o ,E d . ,
pp. 995–1015, John Wiley & Sons, Hoboken, NJ, USA, 3rd
edition, 2004.
[17] S. C. L. Gough, “A review of human and analogue insulin
trials,” Diabetes Research and Clinical Practice, vol. 77, no. 1,
pp. 1–15, 2007.
[18] A. H. Heald, B. Bhattacharya, H. Cooper et al., “Most
commercial insulin assays fail to detect recombinant insulin
analogues,” Annals of Clinical Biochemistry,v o l .4 3 ,n o .4 ,p p .
306–308, 2006.
[19] L. Chaillous, H. Lef` evre, C. Thivolet et al., “Oral insulin
administration and residual β-cell function in recent-onset
type 1 diabetes: a multicentre randomised controlled trial,”
The Lancet, vol. 356, no. 9229, pp. 545–549, 2000.
[ 2 0 ]D .A .S c h a t z ,D .G .R o g e r s ,a n dB .H .B r o u h a r d ,“ P r e v e n t i o n
of insulin-dependent diabetes mellitus: an overview of three
trials,” Cleveland Clinic Journal of Medicine,v o l .6 3 ,n o .5 ,p p .
270–274, 1996.
[21] S. G. A. Gimeno and J. M. P. De Souza, “IDDM and milk
consumption. a case-control study in S˜ ao Paulo, Brazil,”
Diabetes Care, vol. 20, no. 8, pp. 1256–1260, 1997.
[22] E. Savilahti and K. M. Saarinen, “Early infant feeding and type
1 diabetes,” European Journal of Nutrition,v o l .4 8 ,n o .4 ,p p .
243–249, 2009.
[23] R. M. Viner, P. C. Hindmarsh, B. Taylor, and T. J. Cole,
“Childhood body mass index (BMI), breastfeeding and risk
of type 1 diabetes: ﬁndings from a longitudinal national birth
cohort,” DiabeticMedicine,vol.25,no.9,pp.1056–1061,2008.
[24] J. Schrezenmeir and A. Jagla, “Milk and diabetes,” Journal of
the American College of Nutrition,v o l .1 9 ,n o .2 ,s u p p l e m e n t ,
pp. 176S–190S, 2000.
[25] P. G. Arthur, M. Smith, and P. E. Hartmann, “Milk lactose,
citrate, and glucose as markers of lactogenesis in normal and
diabetic women,” Journal of Pediatric Gastroenterology and
Nutrition, vol. 9, no. 4, pp. 488–496, 1989.
[26] S. Lindpointer, S. Korsatko, G. Kohler et al., “Use of the site
of subcutaneous insulin adminsitration for the measurement
of glucose in patients with type 1 diabetes,” Diabetes Care, vol.
33, pp. 595–601, 2010.
[27] T. Lindstr¨ o m ,C .A .H e d m a n ,a n dH .J .A r n q v i s t ,“ U s eo fa
novel double-antibody technique to describe the pharmacoki-
netics of rapid-acting insulin analogs,” Diabetes Care, vol. 25,
no. 6, pp. 1049–1054, 2002.
[28] A. Lucas, J. A. H. Gibbs, R. L. J. Lyster, and J. D. Baum,
“Creamatocrit: simple clinical technique for estimating fat
concentration and energy value of human milk,” British
Medical Journal, vol. 1, no. 6119, pp. 1018–1020, 1978.
[29] M. C. Neville, W. W. Hay, and P. Fennessey, “Physiological
signiﬁcance of the concentration of human milk glucose,”
Protoplasma, vol. 159, no. 2-3, pp. 118–128, 1990.
[30] J. Nowak and J. Nowak, “Changes of insulin concentration
in colostrum and milk of women, cows and sows,” Acta
Physiologica Polonica, vol. 40, no. 4, pp. 349–355, 1989.
[31] L.M.Powell,S.C.Wallis,R.J.Pease,Y.H.Edwards,T.J.Knott,
and J. Scott, “A novel form of tissue-speciﬁc RNA processing
produces apolipoprotein-B48 in intestine,” Cell,v o l .5 0 ,n o .6 ,
pp. 831–840, 1987.
[32] T. M. Devlin, Textbook of Biochemistry With Clinical Correla-
tions, Wiley-Liss, New York, NY, USA, 5th edition, 2002.
[33] A. M. Bonser and P. Garcia-Webb, “C-peptide measurement:
methods and clinical utility,” Critical Reviews in Clinical
Laboratory Sciences, vol. 19, no. 4, pp. 297–352, 1984.
[34] S. Madsbad, G. F. Bottazzo, A. G. Cudworth, B. Dean, O.
K. Faber, and C. Binder, “Islet cell antibodies and beta cellInternational Journal of Endocrinology 9
function in insulin dependent diabetics,” Diabetologia, vol. 18,
no. 1, pp. 45–47, 1980.
[35] R. G. Jensen, Handbook of Milk Composition, Academic Press,
San Diego, Calif, USA, 1995.
[36] W. A. Banks, “The source of cerebral insulin,” European
Journal of Pharmacology, vol. 490, no. 1–3, pp. 5–12, 2004.
[ 3 7 ]H .W a n g ,Z .L i u ,G .L i ,a n dE .J .B a r r e t t ,“ T h ev a s c u l a r
endothelial cell mediates insulin transport into skeletal mus-
cle,” American Journal of Physiology, vol. 291, no. 2, pp. E323–
E332, 2006.
[38] K. J. Hunt and K. L. Schuller, “The increasing prevalence of
diabetes in pregnancy,” Obstetrics and Gynecology Clinics of
North America, vol. 34, no. 2, pp. 173–199, 2007.
[39] G. Sesti, M. Federici, D. Lauro, P. Sbraccia, and R. Lauro,
“Molecular mechanism of insulin resistance in type 2 dia-
betes mellitus: role of the insulin receptor variant forms,”
Diabetes/Metabolism Research and Reviews, vol. 17, no. 5, pp.
363–373, 2001.
[40] M. B. Jackson, C. J. Lammi-Keefe, R. G. Jensen, S. C. Couch,
and A. M. Ferris, “Total lipid and fatty acid composition
of milk from women with and without insulin-dependent
diabetes mellitus,” American Journal of Clinical Nutrition, vol.
60, no. 3, pp. 353–361, 1994.
[41] B. Mosinger, Z. Placer, and O. Koldovsky, “Passage of insulin
throughthewallofthegastro-intestinaltractoftheinfantrat,”
Nature, vol. 184, 16, pp. 1245–1246, 1959.
[42] S. Deshpande and M. W. Platt, “The investigation and
management of neonatal hypoglycaemia,” Seminars in Fetal
and Neonatal Medicine, vol. 10, no. 4, pp. 351–361, 2005.